{"id":2401,"date":"2014-07-14T03:34:16","date_gmt":"2014-07-14T00:34:16","guid":{"rendered":"http:\/\/localhost\/COLAB\/Vires\/WordPress\/?p=61"},"modified":"2021-04-23T06:47:50","modified_gmt":"2021-04-23T06:47:50","slug":"cml-horizon-2014","status":"publish","type":"post","link":"https:\/\/leukeemia.ee\/ru\/cml-horizon-2014\/","title":{"rendered":"CML Horizon iga-aastane konverents 2014"},"content":{"rendered":"<h2 style=\"color: #72798a;\">CML Advocacy: Learn. Share. Grow.<br \/>\n2-4 May 2014, Belgrade, Serbia<\/h2>\n<p style=\"color: #445864;\">On 2-4 May 2014, 119 delegates from 58 countries supporting patients and families affected by Chronic Myeloid Leukemia (CML) met in Belgrade (Serbia) to learn from medical experts, share best practice in patient advocacy and grow their organization\u2019s capacity. Again this year, enlightening medical sessions and discussions, inspiring posters and enriching best practice examples served mainly two purposes: to improve the life of patients and empower patient groups!<\/p>\n<p style=\"color: #445864;\">CML Horizons is a fully community-run and multi-sponsored conference, which has evolved from the &#171;New Horizons&#187; conferences 2002-2011. It was run by the CML Advocates Network, hosted by the newly established, non-profit, swiss-based, patient-driven &#171;Leukemia Patient Advocates Foundation&#187; in Switzerland.<\/p>\n<h2 style=\"color: #72798a;\"><\/h2>\n<h2 style=\"color: #72798a;\">Presentations and Video web streams<\/h2>\n<p style=\"color: #445864;\">Click on &#171;PDF&#187;&nbsp; to see all presentations or on &#171;Web Stream&#187; to see the video of the presentation.<\/p>\n<p style=\"color: #445864;\">Please note that the speakers have authorized CML Advocates Network only to provide the PDFs and webstreams on this website, but it is not allowed to upload the PDFs somewhere else! So if you want to share the slides or the webstreams, please do this by linking to this page or the files on this site!<\/p>\n<p style=\"color: #445864;\"><iframe loading=\"lazy\" src=\"http:\/\/www.youtube.com\/embed\/BLiVXt21qjg?rel=0&amp;wmode=opaque\" allowfullscreen=\"allowfullscreen\" width=\"323\" height=\"220\"><\/iframe><\/p>\n<h4 style=\"color: #212b31;\">Welcome<\/h4>\n<ul style=\"color: #445864;\">\n<li style=\"color: #425661;\"><strong>Welcome to Belgrade<\/strong>,&nbsp;by&nbsp;Jelena \u010cugurovi\u0107 (CML Association of Serbia)&nbsp;&#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/411-welcome-speech-cugurovic\/file\" rel=\"nofollow noopener\" target=\"_blank\"><span class=\"outlink\">PDF<\/span><\/a>&nbsp;&#8212;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/youtu.be\/1GzH_Jmq5kg\" rel=\"nofollow noopener\" target=\"_blank\"><span class=\"outlink\">Video Stream<\/span><\/a><\/li>\n<li style=\"color: #425661;\"><strong>Tribute to Prof. John Goldman<\/strong>, by Giora Sharf (CML Advocates Network)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/412-tribute-to-john-goldman-shah\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp;&#8212; Video Stream<\/li>\n<li style=\"color: #425661;\"><strong>Video Message<\/strong>, by Dr. Brian Druker &#8212;&nbsp;&nbsp;<span class=\"outlink\">Video (<a style=\"color: #57717f;\" href=\"http:\/\/youtu.be\/BLiVXt21qjg\" rel=\"nofollow noopener\" target=\"_blank\">English<\/a>&nbsp;&#8212;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/youtu.be\/IrMUUGutGjY\" rel=\"nofollow noopener\" target=\"_blank\">English with German subtitles<\/a>)<\/span><\/li>\n<\/ul>\n<h4 style=\"color: #212b31;\">Parallel pre-meetings<\/h4>\n<ol style=\"color: #445864;\">\n<li style=\"color: #425661;\"><strong>CML basics and CML 101<\/strong>&nbsp;(Pat Garcia-Gonzalez, Mar\u00eda Isabel G\u00f3mez de Soriano)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/430-cmlhz14-fri1-1-garcia-gonzalez-101-session-pat-maria-isabel-1-4\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/youtu.be\/d8qUHeq7nnY\" rel=\"nofollow noopener\" target=\"_blank\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>How CML patient advocates could engage in CML research<\/strong>&nbsp;(Jan Geissler, Mina Daban, Felice Bombaci)&nbsp;&nbsp;&#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/410-patient-advocates-in-research-geissler\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a><\/li>\n<\/ol>\n<h4 style=\"color: #212b31;\">Advocacy-Session #1: Presenting the regions &#8212; initiatives, priorities and main challenges of each region and how the CML Advocates Network helps addressing them<\/h4>\n<ul style=\"color: #445864;\">\n<li style=\"color: #425661;\"><strong>Latin America&nbsp;<\/strong>(Pat Garcia-Gonzalez)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/413-region-latin-america-garcia-gonzalez\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=O2ee0qQoZTM\" rel=\"nofollow noopener\" target=\"_blank\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>Africa &amp; Middle East&nbsp;<\/strong>(Bahija Gouimi)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/403-region-africa-gouimi\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=AT-1Sho8dEw\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>Asia-Pacific&nbsp;<\/strong>(Zhengchen Liu)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/404-region-asia-pacific-liu\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=67i_SWtCEqU\" rel=\"nofollow noopener\" target=\"_blank\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>North America&nbsp;<\/strong>(Greg Stephens)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/405-region-north-america-stephens\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=MarK_A08LL4\" rel=\"nofollow noopener\" target=\"_blank\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>Europe&nbsp;<\/strong>(Jan Geissler)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/406-region-europe-geissler\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/youtu.be\/l5LErwESp2E\" rel=\"nofollow noopener\" target=\"_blank\">Video Stream<\/a><\/li>\n<\/ul>\n<h4 style=\"color: #212b31;\">Medical Session #1: CML Update<\/h4>\n<ul style=\"color: #445864;\">\n<li style=\"color: #425661;\"><strong>Update on available treatments&nbsp;<\/strong>(Neil Shah)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/407-update-on-available-treatments-shah\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=xhS7ZC3B9uc\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>Update on ELN therapy recommendations&nbsp;<\/strong>(Giuseppe Saglio)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/408-eln-recommendations-saglio\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=ZUqw-M8XDMA\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>Today\u2019s role of transplant in CML &#8212; only for blast crisis or earlier?&nbsp;<\/strong>(Qian Jiang)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/409-transplant-jiang\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=b8tGesdmZvs\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<\/ul>\n<h4 style=\"color: #212b31;\">Medical Session #2: CML in real life, comorbidities&nbsp;and drug interaction<\/h4>\n<ul style=\"color: #445864;\">\n<li style=\"color: #425661;\"><strong>CML in real life: The importance of quality of care &amp; how to treat patients in countries with limited resources<\/strong>&nbsp;(Andrija Bogdanovic)&nbsp; &#8212;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/421-cml-in-real-life-bogdanovic\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=BY3BA8Olu-g\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>Long-term side effects and comorbidities<\/strong>&nbsp;(Neil Shah)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/422-long-term-tki-side-effects-shah\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=59X7suHb73M\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>D<\/strong><strong>rug Interactions from a pharmacology perspective<\/strong>&nbsp;(Annette Freidank)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/429-interactions-freidank\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=LPMbclpnBwM\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<\/ul>\n<h4 style=\"color: #212b31;\">Advocacy-Session #2: Hands-on use of Social Media by Patient Organisations<\/h4>\n<ul style=\"color: #445864;\">\n<li style=\"color: #425661;\"><strong>How to maximize Facebook and Twitter to reach a broader patient audience<\/strong>&nbsp;(Martin Godfrey &#8212; 3 Monkeys)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/415-social-media-godfrey\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=qRQyVO-TpGg\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<\/ul>\n<h4 style=\"color: #212b31;\">Advocacy-Session #3: Developing and implementing an Advocacy Strategy<strong><br \/>\n<\/strong><\/h4>\n<ul style=\"color: #445864;\">\n<li style=\"color: #425661;\"><strong>Strategy &amp; Best Practice Example &#171;EATG Community Advisory Boards&#187;<\/strong>&nbsp;(Tam\u00e1s Bereczky &#8212; EATG)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/416-advocacy-strategy-bereczky\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=2gGHMfV1T7w\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<\/ul>\n<h4 style=\"color: #212b31;\">Medical Session #3:&nbsp;The new realities: Generics and Copy Drugs in CML<\/h4>\n<ul style=\"color: #445864;\">\n<li style=\"color: #425661;\"><strong>Generics, copies &amp; substandard drugs, How to assess quality of drugs and labs<\/strong>&nbsp;(Yoseph Caraco)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/417-generics-substandard-drugs-drug-quality-caraco\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=URm1FCREuJg\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>CML generics from a patient perspective<\/strong>&nbsp;(Cheryl-Anne Simoneau)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/418-generics-from-a-patient-perspective-simoneau\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=vFiVrwLYQOc\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>CML generics from a hematologist perspective<\/strong>&nbsp;(Andrija Bogdanovic)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/419-generics-from-a-hematologist-perspective-bogdanovic\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=rpccnOJIOAo\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\">C<strong>ML generics from a hematologist perspective<\/strong>&nbsp;(Qian Jiang)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/420-generics-from-a-hematologist-perspective-jiang\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=R6_c1scz1Ok\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<\/ul>\n<h4 style=\"color: #212b31;\">Medical Session #4: Treatment-Free Remission, or Eradicating CML?<\/h4>\n<ul style=\"color: #445864;\">\n<li style=\"color: #425661;\"><strong>STOP trials \u2013 results, learnings and outlook&nbsp;<\/strong>(Giuseppe Saglio)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/427-stop-trials-results-learnings-outlook-saglio\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=BMKpqY1MjoY\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>The concept of STOP trials &#8212; is there a new role for Interferon?&nbsp;<\/strong>(Susanne Sau\u00dfele)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/431-the-concept-of-stop-trials-new-role-for-ifn-saussele\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=Iz49MYQTOUg\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>Outlook &#8212; The future of CML therapy<\/strong>&nbsp;(Neil Shah)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/425-outlook-future-cml-treatments-shah\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=LGyU4Jtmcog\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<\/ul>\n<h4 style=\"color: #212b31;\">Advocacy-Session #4: Supporting people living with CML<\/h4>\n<ul style=\"color: #445864;\">\n<li style=\"color: #425661;\"><strong>Book presentation:<\/strong><strong>\u201cLe Livre Blanc des Etats Generaux de la LMC\u201c &#8212;&nbsp;from the first general state of the LMC&nbsp;<\/strong>(Mina &amp; St\u00e9phane Daban &#8212; LMC France,&nbsp;France)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/424-book-presentation-le-livre-blanc-daban\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=FnNn30dUz1E\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>Managing distress as an advocate<\/strong>&nbsp;(Gail Sperling &#8212; The Leukemia &amp; Lymphoma Society, USA)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/423-managing-distress-as-an-advocate-sperling\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/watch?v=nuvzd6-qB5o\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<li style=\"color: #425661;\"><strong>Sex, self-esteem and a chronic disease<\/strong>&nbsp;(Sarah Liptrott &#8212; European Institute of Oncology, Italy)&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"http:\/\/www.cmladvocates.net\/download\/cml-horizons-conferences\/cml-horizons-2014\/presentations-6\/428-sex-self-esteem-and-chronic-disease-liptrott\/file\" rel=\"nofollow noopener\" target=\"_blank\">PDF<\/a>&nbsp; &#8212;&nbsp;&nbsp;<a style=\"color: #57717f;\" href=\"https:\/\/www.youtube.com\/edit?video_id=kriAzyTS3oM&amp;video_referrer=watch\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Video Stream<\/a><\/li>\n<\/ul>\n<h2 style=\"color: #72798a;\"><\/h2>\n<h2 style=\"color: #72798a;\">CML Steering Committee<\/h2>\n<p style=\"color: #445864;\">The programme has been governed by a global steering committee consisting of CML patient advocates from North America, Latin America, Asia, Europe, Middle East and Africa. The CML Steering Committee 2013-2015 is:<\/p>\n<ul style=\"color: #445864;\">\n<li style=\"color: #425661;\">Gina Russo \/ Gail Sperling (USA\/North America)<\/li>\n<li style=\"color: #425661;\">Bahija Gouimi (Morocco\/Africa)<\/li>\n<li style=\"color: #425661;\">Mina Daban (France\/Europe)<\/li>\n<li style=\"color: #425661;\">Giora Sharf (Israel\/Middle East)<\/li>\n<li style=\"color: #425661;\">Jan Geissler (Germany\/Europe)<\/li>\n<li style=\"color: #425661;\">Jana Pelouchov\u00e1 (Czech Rep.\/Europe)<\/li>\n<li style=\"color: #425661;\">Pat Garcia-Gonzalez (USA\/Latin America)<\/li>\n<li style=\"color: #425661;\">Zhengchen Liu (China\/Asia-Pacific)<\/li>\n<\/ul>\n<p style=\"color: #445864;\">For any questions regarding the conference, please contact the conference coordinators Giora Sharf,&nbsp;<a style=\"color: #57717f;\" href=\"mailto:giora@cmladvocates.net\">giora@cmladvocates.net<\/a>&nbsp;and Jan Geissler,&nbsp;<a style=\"color: #57717f;\" href=\"mailto:jan@cmladvocates.net\">jan@cmladvocates.net<\/a><\/p>\n<h2 style=\"color: #72798a;\">Sponsorship Acknowledgement<\/h2>\n<p style=\"color: #445864;\">We would like to thank the following organisations for providing unconditional educational funding. Without their support, this conference would not be possible:<\/p>\n<ul style=\"color: #445864;\">\n<li style=\"color: #425661;\">Novartis Oncology (Initiating platinum sponsor)<\/li>\n<li style=\"color: #425661;\">Bristol-Myers Squibb (Gold Sponsor)<\/li>\n<li style=\"color: #425661;\">Pfizer Oncology (Gold Sponsor)<\/li>\n<li style=\"color: #425661;\">Ariad (Bronze Sponsor)<\/li>\n<li style=\"color: #425661;\">The Leukemia &amp; Lymphoma Society (Bronze Sponsor)<\/li>\n<li style=\"color: #425661;\">International CML Foundation (Bronze Sponsor)<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>CML Advocacy: Learn. Share. Grow. 2-4 May 2014, Belgrade, Serbia On 2-4 May 2014, 119 delegates from 58 countries supporting patients and families affected by Chronic Myeloid Leukemia (CML) met in Belgrade (Serbia) to learn from medical experts, share best practice in patient advocacy and grow their organization\u2019s capacity. Again this year, enlightening medical sessions &hellip; <a href=\"https:\/\/leukeemia.ee\/ru\/cml-horizon-2014\/\">Continued<\/a><\/p>\n","protected":false},"author":6,"featured_media":2103,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4],"tags":[],"class_list":["post-2401","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uudised"],"acf":[],"_links":{"self":[{"href":"https:\/\/leukeemia.ee\/ru\/wp-json\/wp\/v2\/posts\/2401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leukeemia.ee\/ru\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/leukeemia.ee\/ru\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/leukeemia.ee\/ru\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/leukeemia.ee\/ru\/wp-json\/wp\/v2\/comments?post=2401"}],"version-history":[{"count":1,"href":"https:\/\/leukeemia.ee\/ru\/wp-json\/wp\/v2\/posts\/2401\/revisions"}],"predecessor-version":[{"id":2402,"href":"https:\/\/leukeemia.ee\/ru\/wp-json\/wp\/v2\/posts\/2401\/revisions\/2402"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leukeemia.ee\/ru\/wp-json\/wp\/v2\/media\/2103"}],"wp:attachment":[{"href":"https:\/\/leukeemia.ee\/ru\/wp-json\/wp\/v2\/media?parent=2401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leukeemia.ee\/ru\/wp-json\/wp\/v2\/categories?post=2401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leukeemia.ee\/ru\/wp-json\/wp\/v2\/tags?post=2401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}